Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Digital Officer Adnan R. Mansour received an equity grant in the form of 23,441 restricted stock units (RSUs), each representing one share of common stock at no purchase price.
The RSUs will vest in approximately equal installments on February 4, 2027, 2028 and 2029, as long as Mansour continues to serve the company on each vesting date. This award increases his directly held equity stake and further links his compensation to the company’s long-term stock performance.
Alignment Healthcare President Dawn Christine Maroney sold 30,000 shares of common stock in an open-market transaction. The sale on 2026-02-17 was executed under a Rule 10b5-1 trading plan adopted on 05/22/2025, at a weighted-average price of $20.633 per share. After this transaction, she directly holds 997,015 shares of Alignment Healthcare common stock.
General Atlantic-affiliated funds filed an amended Schedule 13G reporting a sizable stake in Alignment Healthcare, Inc. As of December 31, 2025, General Atlantic (ALN HLTH), L.P. held 13,167,733 shares of Alignment’s Class A common stock, representing 6.6% of the outstanding shares.
Various General Atlantic entities, including General Atlantic, L.P. and several GAPCO and coinvestment vehicles, may be deemed to share beneficial ownership and voting and disposition power over these shares through their control relationships, but GA ALN is the record holder.
Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported a sale of company common stock on a Form 4. On February 10, 2026, he sold 22,238 shares of common stock at $20.47 per share and held 169,805 shares afterward, all directly owned.
According to the footnote, these shares were sold solely to cover tax withholding obligations arising from the vesting of restricted share units. The filing states this was not a discretionary trade by the reporting person, indicating the sale was linked to equity compensation rather than an open-market portfolio decision.
Alignment Healthcare reported that JEK Trust, of which Chief Executive Officer and director John E. Kao is trustee, sold 180,000 shares of the company’s common stock on 02/10/2026 at a weighted-average price of $20.4853 per share under a Rule 10b5-1 trading plan adopted on 03/12/2025.
After this sale, 2,652,641 shares are held indirectly through JEK Trust and 1,568,379 shares are held directly. The sale price reflects multiple trades in a range from $20.23 to $20.66 per share.
Wellington Management Group and affiliates report a significant institutional stake in Alignment Healthcare, Inc. They beneficially own 14,070,893 shares of Alignment Healthcare common stock, representing about 7.3%–7.34% of the class as of 12/31/2025.
The shares are owned of record by clients of various Wellington investment advisers, while the Wellington entities report shared voting and shared dispositive power over most of these shares and no sole power. They state the holdings are maintained in the ordinary course of business and not for the purpose of changing or influencing control of Alignment Healthcare.
Alignment Healthcare, Inc. filed a notice of proposed sale of 22,500 shares of its common stock under Rule 144. The planned sale through E-Trade Finance has an aggregate market value of $489,375 and is targeted for around February 10, 2026 on the Nasdaq Stock Market.
The seller previously acquired 38,941 common shares on February 7, 2024 as a stock award under the company’s 2021 Equity Incentive Plan. Shares outstanding were 200,091,742 at the time referenced, providing context for the scale of the planned sale.
FMR LLC has disclosed a significant passive ownership stake in Alignment Healthcare Inc. common stock. As of December 31, 2025, FMR LLC and related reporting person Abigail P. Johnson beneficially owned 14,792,081.57 shares, representing 7.7% of Alignment Healthcare’s outstanding common stock.
FMR LLC reports sole voting power over 14,776,171.28 shares and sole dispositive power over 14,792,081.57 shares, with no shared voting or dispositive power. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The Vanguard Group reports beneficial ownership of 15,492,802 shares of Alignment Healthcare Inc common stock, representing 7.74% of the class as of the reported date. Vanguard has shared voting power over 1,275,363 shares and shared dispositive power over all 15,492,802 shares, with no sole voting or dispositive power.
The holdings are managed in the ordinary course of business and not for the purpose of changing or influencing control of Alignment Healthcare. Vanguard’s clients have the right to receive dividends and sale proceeds from these securities, and no single client holds more than 5% of the class. Vanguard also notes an internal realignment on January 12, 2026, after which certain subsidiaries are expected to report beneficial ownership separately.
Alignment Healthcare, Inc. executive Adnan R. Mansour, the company’s Chief Digital Officer, filed an initial insider ownership report. This filing states that he does not beneficially own any Alignment Healthcare securities. Both the non-derivative and derivative securities tables show no holdings, and the remarks section explicitly notes that no securities are beneficially owned. The form is filed as a single-reporting-person filing and is signed by an attorney-in-fact under a power of attorney.